Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Sarcoma, Ewing × Alemtuzumab × Clear all

Sponsor

Conditions

Leukemia 27 Leukemia, Lymphocytic, Chronic, B-Cell 24 Lymphoma 16 Myelodysplastic Syndromes 11 Hodgkin Disease 11 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Multiple Myeloma 7 Leukemia, Myeloid, Acute 7 Lymphoma, Non-Hodgkin 6 Lymphoma, Follicular 6 Recurrence 5 Myeloproliferative Disorders 5 Lymphoma, Mantle-Cell 5 Lymphoma, Large B-Cell, Diffuse 5 Leukemia, Myeloid, Chronic-Phase 5 Hematologic Neoplasms 5 Lymphoma, T-Cell, Cutaneous 4 Lymphoma, B-Cell, Marginal Zone 4 Anemia, Aplastic 4 Waldenstrom Macroglobulinemia 3 Sezary Syndrome 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Mycosis Fungoides 3 Lymphoma, T-Cell, Peripheral 3 Lymphoma, Large-Cell, Anaplastic 3 Lymphoma, Extranodal NK-T-Cell 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Leukemia, Large Granular Lymphocytic 3 Immunoblastic Lymphadenopathy 3 Hematologic Diseases 3

Interventions

Irinotecan 6 Temozolomide 5 Cyclophosphamide 5 Vincristine 4 Doxorubicin 4 Magnetic Resonance Spectroscopy 3 palbociclib 2 ganitumab 2 eribulin 2 cixutumumab 2 abemaciclib 2 X-Rays 2 Radiotherapy, Image-Guided 2 Radiosurgery 2 Phantoms, Imaging 2 Peripheral Blood Stem Cell Transplantation 2 Nivolumab 2 Gemcitabine 2 FANG vaccine 2 Etoposide 2 ulixertinib 1 tipifarnib 1 temsirolimus 1 tazemetostat 1 talazoparib 1 surufatinib 1 selpercatinib 1 robatumumab 1 pegfilgrastim 1 olaparib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡